{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:44:48Z","timestamp":1792421088794,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.jinf.2010.10.009","type":"journal-article","created":{"date-parts":[[2010,11,4]],"date-time":"2010-11-04T04:18:00Z","timestamp":1288844280000},"page":"159-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis"],"prefix":"10.1016","volume":"62","author":[{"given":"Seung Soon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngsu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doo Ryeon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1A","key":"10.1016\/j.jinf.2010.10.009_bib1","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/S0002-9343(02)01054-9","article-title":"Epidemiology of urinary tract infections: incidence, morbidity, and economic costs","volume":"113","author":"Foxman","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.jinf.2010.10.009_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/519268","article-title":"Population-based epidemiologic analysis of acute pyelonephritis","volume":"45","author":"Czaja","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.10.009_bib3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/520427","article-title":"Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA)","volume":"29","author":"Warren","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.10.009_bib4","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1086\/592250","article-title":"Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis","volume":"47","author":"Talan","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.10.009_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jac\/dkg028","article-title":"An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project","volume":"51","author":"Kahlmeter","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2010.10.009_bib6","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.amjmed.2008.04.039","article-title":"Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates","volume":"121","author":"Johnson","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.jinf.2010.10.009_bib7","first-page":"277","article-title":"Antimicrobial susceptibility of causative microorganisms in adults with acute pyelonephritis at one university-affiliated hospital in southwestern Seoul","volume":"35","author":"Hwang","year":"2003","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jinf.2010.10.009_bib8","first-page":"571","article-title":"Quinolone resistance in community-acquired acute pyelonephritis","volume":"25","author":"Kim","year":"2006","journal-title":"Korean J Nephrol"},{"key":"10.1016\/j.jinf.2010.10.009_bib9","first-page":"9","article-title":"Clinical Features and antimicrobial resistance among clinical isolates of women with community-acquired acute pyelonephritis in 2001\u20132006","volume":"39","author":"Wie","year":"2007","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jinf.2010.10.009_bib10","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jama.283.12.1583","article-title":"Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women","volume":"283","author":"Talan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jinf.2010.10.009_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7326\/0003-4819-135-1-200107030-00012","article-title":"Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections","volume":"135","author":"Gupta","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2010.10.009_bib12","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1056\/NEJM197411282912204","article-title":"Serum versus urinary antimicrobial concentrations in cure of urinary-tract infections","volume":"291","author":"Stamey","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2010.10.009_bib13","series-title":"Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases","first-page":"875","article-title":"Urinary tract infections","author":"Sobel","year":"2005"},{"key":"10.1016\/j.jinf.2010.10.009_bib14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/0003-4819-115-8-585","article-title":"Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy","volume":"115","author":"Chow","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2010.10.009_bib15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/clinids\/20.2.296","article-title":"Enterococcus facium and Enterococcus faecalis bacteremia: acquisition and outcome","volume":"20","author":"Noskin","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.10.009_bib16","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00003246-199206000-00025","article-title":"definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"20","year":"1992","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jinf.2010.10.009_bib17","series-title":"Performance standards for antimicrobial susceptibility testing: 15th informational supplement: approved standard M100-S15","year":"2005"},{"key":"10.1016\/j.jinf.2010.10.009_bib18","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1086\/340616","article-title":"Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization","volume":"34","author":"Blot","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.10.009_bib19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00000441-200610000-00004","article-title":"The clinical impact of bacteremia in complicated acute pyelonephritis","volume":"332","author":"Hsu","year":"2006","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jinf.2010.10.009_bib20","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1086\/323810","article-title":"Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections","volume":"33","author":"Velasco","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.10.009_bib21","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1086\/342955","article-title":"Are quinolone-resistant uropathogenic Escherichia coli less virulent?","volume":"186","author":"Vila","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2010.10.009_bib22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s100960050332","article-title":"Invasive disease caused by ciprofloxacin-resistant uropathogenic Escherichia coli","volume":"18","author":"Blazquez","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2010.10.009_bib23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jac\/dkm279","article-title":"Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteremia","volume":"60","author":"Peralta","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2010.10.009_bib24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/BF02447917","article-title":"Five-year prospective study of bacteraemic urinary tract infection in a single institution","volume":"16","author":"Bishara","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2010.10.009_bib25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1086\/432940","article-title":"Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inappropriate empirical antimicrobial therapy","volume":"41","author":"Lautenbach","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.10.009_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/jac\/dkp162","article-title":"Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998\u20132007","volume":"64","author":"Al-Hasan","year":"2009","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445310003245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445310003245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:14:14Z","timestamp":1759007654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445310003245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0163445310003245"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2010.10.009","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2010.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}